Real-life experience using trabectedin plus pegylated liposomal doxorubicin combination to treat patients with relapsed ovarian cancer

The goal of recurrent ovarian cancer (ROC) treatment is no longer just palliation, but prolonging survival. This is usually through administering a new line of chemotherapy at each relapse. A novel treatment sequencing strategy to achieve this is through the intercalation of an effective non-platinu...

Descripción completa

Detalles Bibliográficos
Autor principal: Tahir, Saad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2014
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4683382/
https://www.ncbi.nlm.nih.gov/pubmed/26759528
http://dx.doi.org/10.1016/S1359-6349(15)70006-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4683382/
https://www.ncbi.nlm.nih.gov/pubmed/26759528
http://dx.doi.org/10.1016/S1359-6349(15)70006-6

Ejemplares similares